TREATMENT OF NEURODEGENERATIVE DISEASES BY THE USE OF ATP7A INHIBITORS

摘要

a. identifying of a ATP7A-interacting molecule by determining whether a given test compound is a ATP7A-interacting molecule, b. determining whether the ATP7A-interacting molecule of step a) is capable of modulating gamma-secretase and/or beta-secretase activity.